Raajit Rampal, MD, Oncology, New York, NY, Memorial Sloan-Kettering Cancer Center

RaajitRampalMD

Oncology New York, NY

Hematologic Oncology

Physician

Dr. Rampal is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rampal's full profile

Already have an account?

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFELLOWSHIP
  • University of Chicago
    University of ChicagoRESIDENCY
  • Stony Brook University School of Medicine
    Stony Brook University School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2020 - Present
  • NY State Medical License
    NY State Medical License 2009 - 2022
  • IL State Medical License
    IL State Medical License 2007 - 2010
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Jak2V617F and Dnmt3a Loss Cooperate to Induce Myelofibrosis Through Activated Enhancer-Driven Inflammation  
    Raajit Rampal, MD, Blood

Abstracts/Posters

  • Expansion of Prior Existing TP53 Mutated Clones in Polycythemia Vera Patients Treated with Idasanutlin
    Raajit K. Rampal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • The Genetic Architecture of Myeloproliferative Neoplasms-Blast Phase (MPN-BP) Stem Cells
    Raajit K. Rampal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms
    Raajit K. Rampal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Safety and Efficacy of Combined Ruxolitinib and Thalidomide in Patients with Myelofibrosis: A Phase II Study 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Approaches to the Individualized Management of MPNs: Best Practices and Guidance to Optimize Care 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Hematologic Malignancies Arising in Patients with Germ Cell Tumors: Secondary Somatic Differentiation of Hematopoietic Malignancies from Germ Cell Precursors 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Constellation Pharmaceuticals to Host Analyst/Investor Meeting at ASCO to Discuss Interim Update of Data of CPI-0610 in MANIFEST Clinical Trial
    Constellation Pharmaceuticals to Host Analyst/Investor Meeting at ASCO to Discuss Interim Update of Data of CPI-0610 in MANIFEST Clinical TrialMay 23, 2019
  • Constellation Pharmaceuticals Announces First-Quarter 2019 Financial Results
    Constellation Pharmaceuticals Announces First-Quarter 2019 Financial ResultsMay 08, 2019
  • Back to the Drawing Board for MPN Combo
    Back to the Drawing Board for MPN ComboApril 18, 2019

Hospital Affiliations